Heroes in Drug Discovery
Join Drew University for an evening celebrating
profound advances in medicinal chemistry at
Heroes in Drug Discovery.
This award celebrates scientists who have made significant contributions to human healthcare.
Drew University’s Research Institute for Scientists Emeriti (RISE) will honor the Vertex drug discovery team members as the recipients of the Heroes in Drug Discovery Award for the discovery of breakthrough drugs for the treatment of cystic fibrosis (CF).
CF is a progressive hereditary disease that affects the lungs, digestive system and other organs. Patients with CF have a shorter than normal lifespan. The Vertex team’s research effort led to the discovery of a portfolio of breakthrough drugs, Kalydeco (ivacaftor), lumacaftor and tezacaftor to treat CF patients.
After the presentation of the award, join Dr. Mark Miller, director at Vertex Pharmaceuticals, for a seminar entitled “Discovery of CFTR modulators for the treatment of Cystic Fibrosis,” describing the team’s outstanding research efforts. The evening concludes with a reception to celebrate their accomplishments.
This event is made possible through the generous support of Pfizer and the Independent College Fund of New Jersey (ICFNJ).